J 2017

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements

VARDI, A.; E. VLACHONIKOLA; M. KARYPIDOU; E. STALIKA; Vasileios BIKOS et. al.

Basic information

Original name

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements

Authors

VARDI, A. (300 Greece); E. VLACHONIKOLA (300 Greece); M. KARYPIDOU (300 Greece); E. STALIKA (300 Greece); Vasileios BIKOS (300 Greece, belonging to the institution); K. GEMENETZI (300 Greece); C. MARAMIS (300 Greece); A. SIORENTA (300 Greece); A. ANAGNOSTOPOULOS (300 Greece); Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution); N. MAGLAVERAS (300 Greece); I. CHOUVARDA (300 Greece); K. STAMATOPOULOS (300 Greece) and A. HADZIDIMITRIOU (300 Greece)

Edition

Leukemia, London, Nature Publishing Group, 2017, 0887-6924

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 10.023

RIV identification code

RIV/00216224:14740/17:00097384

Organization unit

Central European Institute of Technology

UT WoS

000404745300010

EID Scopus

2-s2.0-85007559147

Keywords in English

CLONAL EVOLUTION; CONVERGENT RECOMBINATION; TARGETED THERAPIES; MOUSE MODEL; RECEPTORS; LENALIDOMIDE; IBRUTINIB; DRIVEN; CLL; CHEMOIMMUNOTHERAPY

Tags

Tags

International impact, Reviewed
Changed: 28/2/2018 16:39, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Immunoglobulin (IG) gene repertoire restrictions strongly support antigen selection in the pathogenesis of chronic lymphocytic leukemia (CLL). Given the emerging multifarious interactions between CLL and bystander T cells, we sought to determine whether antigen(s) are also selecting T cells in CLL. We performed a large-scale, next-generation sequencing (NGS) study of the T-cell repertoire, focusing on major stereotyped subsets representing CLL subgroups with undisputed antigenic drive, but also included patients carrying non-subset IG rearrangements to seek for T-cell immunogenetic signatures ubiquitous in CLL. Considering the inherent limitations of NGS, we deployed bioinformatics algorithms for qualitative curation of T-cell receptor rearrangements, and included multiple types of controls. Overall, we document the clonal architecture of the T-cell repertoire in CLL. These T-cell clones persist and further expand overtime, and can be shared by different patients, most especially patients belonging to the same stereotyped subset. Notably, these shared clonotypes appear to be disease-specific, as they are found in neither public databases nor healthy controls. Altogether, these findings indicate that antigen drive likely underlies T-cell expansions in CLL and may be acting in a CLL subset-specific context. Whether these are the same antigens interacting with the malignant clone or tumor-derived antigens remains to be elucidated.

Links

LM2011020, research and development project
Name: CEITEC ? open access
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR

Files attached